High dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased ...

Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

A large-scale bibliometric analysis maps global research on hydrogels as next-generation drug delivery systems for cancer ...

Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteersFirst-in-human administration of CPV-104 marks a major step in drug development for the ...

An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was successfully treated with corticosteroid therapy. This case report was published ...

Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced the first dosing in its phase 1 clinical study investigating the ...

By Dr. Liji Thomas, MD A major new study maps the rise of hydrogels in cancer therapy, revealing how this flexible material ...

The field of oncology has been revolutionized by the introduction of immune checkpoint inhibitors, with anti-PD-1 therapies offering durable responses in ...

The first thing that comes to mind with the word trained immunity is the immunological training every immune cell acquired during the entire lifespan of an ...